Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction

Background: Cancer is still a major public health issue worldwide, and new therapeutics with anti-tumor activity are still urgently needed. Methods: The anti-tumor activity of TH-39, which shows potent anti-proliferative activity against K562 cells with an IC50 of 0.78 µM, was investigated using imm...

Full description

Bibliographic Details
Main Authors: Yongxia Zhu, Wei Wei, Tinghong Ye, Zhihao Liu, Li Liu, Yong Luo, Lidan Zhang, Chao Gao, Ningyu Wang, Luoting Yu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-11-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/452546
_version_ 1818135000180064256
author Yongxia Zhu
Wei Wei
Tinghong Ye
Zhihao Liu
Li Liu
Yong Luo
Lidan Zhang
Chao Gao
Ningyu Wang
Luoting Yu
author_facet Yongxia Zhu
Wei Wei
Tinghong Ye
Zhihao Liu
Li Liu
Yong Luo
Lidan Zhang
Chao Gao
Ningyu Wang
Luoting Yu
author_sort Yongxia Zhu
collection DOAJ
description Background: Cancer is still a major public health issue worldwide, and new therapeutics with anti-tumor activity are still urgently needed. Methods: The anti-tumor activity of TH-39, which shows potent anti-proliferative activity against K562 cells with an IC50 of 0.78 µM, was investigated using immunoblot, co-immunoprecipitation, the MTT assay, and flow cytometry. Results: Mechanistically, TH-39 may disrupt the interaction between Hec1 and Nek2 in K562 cells. Moreover, TH-39 inhibited cell proliferation in a concentration- and time-dependent manner by influencing the morphology of K562 cells and inducing G0/G1 phase arrest. G0/G1 phase arrest was associated with down-regulation of CDK2-cyclin E complex and CDK4/6-cyclin D complex activities. Furthermore, TH-39 also induced cell apoptosis, which was associated with activation of caspase-3, down-regulation of Bcl-2 expression and up-regulation of Bax. TH-39 could also decrease mitochondrial membrane potential (Δψm) and increase reactive oxygen species (ROS) accumulation in K562 cells. The results indicated that TH-39 might induce apoptosis via the ROS-mitochondrial apoptotic pathway. Conclusion: This study highlights the potential therapeutic efficacy of the anti-cancer compound TH-39 in treatment-resistant chronic myeloid leukemia.
first_indexed 2024-12-11T09:17:33Z
format Article
id doaj.art-b46851583195440bae0fe82750f1fab8
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-11T09:17:33Z
publishDate 2016-11-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-b46851583195440bae0fe82750f1fab82022-12-22T01:13:20ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782016-11-01401-229730810.1159/000452546452546Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis InductionYongxia ZhuWei WeiTinghong YeZhihao LiuLi LiuYong LuoLidan ZhangChao GaoNingyu WangLuoting YuBackground: Cancer is still a major public health issue worldwide, and new therapeutics with anti-tumor activity are still urgently needed. Methods: The anti-tumor activity of TH-39, which shows potent anti-proliferative activity against K562 cells with an IC50 of 0.78 µM, was investigated using immunoblot, co-immunoprecipitation, the MTT assay, and flow cytometry. Results: Mechanistically, TH-39 may disrupt the interaction between Hec1 and Nek2 in K562 cells. Moreover, TH-39 inhibited cell proliferation in a concentration- and time-dependent manner by influencing the morphology of K562 cells and inducing G0/G1 phase arrest. G0/G1 phase arrest was associated with down-regulation of CDK2-cyclin E complex and CDK4/6-cyclin D complex activities. Furthermore, TH-39 also induced cell apoptosis, which was associated with activation of caspase-3, down-regulation of Bcl-2 expression and up-regulation of Bax. TH-39 could also decrease mitochondrial membrane potential (Δψm) and increase reactive oxygen species (ROS) accumulation in K562 cells. The results indicated that TH-39 might induce apoptosis via the ROS-mitochondrial apoptotic pathway. Conclusion: This study highlights the potential therapeutic efficacy of the anti-cancer compound TH-39 in treatment-resistant chronic myeloid leukemia.http://www.karger.com/Article/FullText/452546TH-39Hec1/Nek2K562 cellsG0/G1 cell cycle arrestApoptosis
spellingShingle Yongxia Zhu
Wei Wei
Tinghong Ye
Zhihao Liu
Li Liu
Yong Luo
Lidan Zhang
Chao Gao
Ningyu Wang
Luoting Yu
Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction
Cellular Physiology and Biochemistry
TH-39
Hec1/Nek2
K562 cells
G0/G1 cell cycle arrest
Apoptosis
title Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction
title_full Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction
title_fullStr Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction
title_full_unstemmed Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction
title_short Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction
title_sort small molecule th 39 potentially targets hec1 nek2 interaction and exhibits antitumor efficacy in k562 cells via g0 g1 cell cycle arrest and apoptosis induction
topic TH-39
Hec1/Nek2
K562 cells
G0/G1 cell cycle arrest
Apoptosis
url http://www.karger.com/Article/FullText/452546
work_keys_str_mv AT yongxiazhu smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT weiwei smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT tinghongye smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT zhihaoliu smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT liliu smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT yongluo smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT lidanzhang smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT chaogao smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT ningyuwang smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction
AT luotingyu smallmoleculeth39potentiallytargetshec1nek2interactionandexhibitsantitumorefficacyink562cellsviag0g1cellcyclearrestandapoptosisinduction